title: T cell participation in autoreactivity to NC16a epitopes in bullous pemphigoid.
abstract: Bullous pemphigoid is a blistering skin disease characterized by autoantibodies against the NC16a domain of bullous pemphigoid 180. This study was performed to characterize and map the fine specificity of T cell responses to NC16a. Peripheral blood mononuclear cells (PBMC) from a total of 28 bullous pemphigoid patients and 14 matched controls were tested for proliferative and cytokine responses to recombinant NC16a and a complete panel of 21 overlapping peptides spanning this region of BP180. Proliferative responses to NC16A and the peptide panel in the patients with active disease were similar in frequency and magnitude to those in healthy donors, and included late responses typical of naive cells in approximately 60% of each group. Interleukin (IL)-4 responses were slightly stronger for six peptides, and significantly stronger for Nc16a, in patients than in controls. Factor analysis identified factors that separate responses to the peptide panel discretely into IL-4, T helper type 2 (Th2) pattern, interferon (IFN)-γ, Th1 pattern and IL-10 or transforming growth factor [TGF-β, regulatory T cell (Treg )] pattern. Factors segregating IL-10 versus IFN-γ were predicted by active blistering or remission, and TGF-β or IL-10 versus IFN-γ by age. Finally, we confirmed a significant up-regulation of IgE responses to BP180 in the patients with pemphigoid. This shows the complexity of T cell phenotype and fine autoreactive specificity in responses to NC16A, in patients and in normal controls. Important disease-associated factors determine the balance of cytokine responses. Of these, specific IL-4 and IgE responses show the strongest associations with pemphigoid, pointing to an important contribution by Th2 cytokines to pathogenesis.
authors.affiliation: The Division of Applied Medicine, Institute of Medical Sciences, University of Aberdeen, Aberdeen, UK.
authors.forename: W J
authors.initials: WJ
authors.lastname: Pickford
authors.forename: V
authors.initials: V
authors.lastname: Gudi
authors.forename: A M
authors.initials: AM
authors.lastname: Haggart
authors.forename: B J
authors.initials: BJ
authors.lastname: Lewis
authors.forename: R
authors.initials: R
authors.lastname: Herriot
authors.forename: R N
authors.initials: RN
authors.lastname: Barker
authors.forename: A D
authors.initials: AD
authors.lastname: Ormerod
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000375:Aging / Q000097:blood / Q000276:immunology* / Q000473:pathology; D001324:Autoantigens / Q000097:blood / Q000276:immunology*; D016207:Cytokines / Q000097:blood / Q000276:immunology; D018984:Epitopes, T-Lymphocyte / Q000097:blood / Q000276:immunology*; D005260:Female; D006801:Humans; D007073:Immunoglobulin E / Q000097:blood / Q000276:immunology*; D008297:Male; D008875:Middle Aged; D010391:Pemphigoid, Bullous / Q000097:blood / Q000276:immunology* / Q000473:pathology; D018418:Th2 Cells / Q000276:immunology* / Q000378:metabolism / Q000473:pathology
chemical_list: D001324:Autoantigens; D016207:Cytokines; D018984:Epitopes, T-Lymphocyte; D007073:Immunoglobulin E
keywords: Th1/Th2; autoimmunity; cytokines; regulatory T cells